Ignite Creation Date:
2025-12-25 @ 2:32 AM
Ignite Modification Date:
2025-12-26 @ 1:08 AM
Study NCT ID:
NCT04846634
Status:
NOT_YET_RECRUITING
Last Update Posted:
2021-04-15
First Post:
2021-04-14
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Penpulimab-based Combination Neoadjuvant/Adjuvant Therapy for Patients With Resectable Locally Advanced Non-small Cell Lung Cancer: a Phase II Clinical Study (ALTER-L043)
Sponsor:
Tianjin Medical University Cancer Institute and Hospital
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2021-08
Start Date Type:
ESTIMATED
Primary Completion Date:
2023-03
Primary Completion Date Type:
ESTIMATED
Completion Date:
2028-02
Completion Date Type:
ESTIMATED
First Submit Date:
2021-04-14
First Submit QC Date:
None
Study First Post Date:
2021-04-15
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2021-04-14
Last Update Post Date:
2021-04-15
Last Update Post Date Type:
ACTUAL